Description

This report forecasts the U.S. Congestive Heart Failure(CHF) Medications Market for the period 1997 to 2007, with 2000 as the base year. There are two segments in this market, the ACE inhibitors and the Beta Blockers.This report discusses the challenges,drivers and restraints and their impact on future revenues and growth rates. The competitive structure of the total market,as well as each individual segment is analyzed. Demand analysis, market share analysis and technology trends are discussed. Product analysis in each segment is done and Emerging therapeutics for CHF are also discussed and their likely impact on existing therapies analyzed. Finally, conclusions are inferred and strategic recommendations made.